The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment ...

A new study says that people who use tirzepatide lose more weight than people who use semaglutide Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and ...

The reconciliation package taking shape in the House will add at least $3.3 trillion to the debt through 2034, according to a new analysis by the Committee for a Responsible Federal Budget (CRFB).

Eli Lilly has decided to wait for the readout of the second of its two phase 3 trials for tirzepatide in obesity, rather than filing on the strength of its first, positive study.

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials. OSA is a prevalent ...

People who take slimming injections regain their lost weight when they come off the medication, new research suggests. The study found that even those prescribed the latest jabs returned to their ...

and the dual GLP-1/ glucose-dependent insulinotropic polypeptide agonist tirzepatide (Mounjaro for T2D, Zepbound for weight), are more potent for both conditions than first-generation predecessors ...

She confirmed she was not a healthcare professional and claimed to be selling Mounjaro - the brand name for the weight-loss drug tirzepatide. She was recorded saying that she buys it “in bulk ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change obesity treatment options in India and beyond. Listen to Story Tirzepatide led ...